Modalities
Comprehensive End-to-End Solutions
세포치료제
In Vivo CAR
유전자치료제
치료용항체
ADC
백신
- 초기 연구 & 개발
- CMC - 생산
- CMC - 품질 관리
- 전임상 연구
- 임상 연구
Our Commitment
ACROBiosystems' Core Brand Values
- QUALITY
- INNOVATION
- SERVICE
As we prepare for an international multicentric controlled Phase 3 study evaluating the safety and efficacy of ProtheraCytes in post-acute myocardial infarction patients, we chose ACROBiosystems GMP proteins for their level of documentation, quality control, and regulatory compliance to meet our future commercialization demands.
QUALITY Customer Story
Ibon Garitaonandia, Ph.D., MBA
Chief Scientific Officer, CellProthera
Our Global Reach
Dedicated Local Support, Always on Standby
- Offices
- R&D Centers
- Manufacturing Bases
- Logistics Hubs
London, United Kingdom
Frankfurt, Germany
Paris, France
Basel, Switzerland
Boston, MA, USA
Newark, DE, USA
San Diego, CA, USA
Beijing, China
Seoul, South Korea
Nanjing, China
Suzhou, China
Shanghai, China
Tokyo, Japan
Hangzhou, China
Hong Kong, China
San Jose, CA, USA
Customers
Locations
Employees
- Events
- Activities
North America
ISSCR Annual Meeting 2026
Learn MoreEurope
The 10th Bioproduction Congress 2025
Learn MoreAsia Pacific
